Pharmacy Benefit Management - PolicyEdge AI — AI & Policy Intelligence for Decision Makers

Abstract data flows represent Florida PBM lawsuit oversight, pharmacy reimbursement, and traceable plan economics.

Pharmacy Benefit Management

Florida PBM Lawsuit: The Missing Audit Trail Behind Drug-Benefit Savings

Florida’s PBM lawsuit against Prime Therapeutics and Express Scripts raises a larger oversight question: who controls pharmacy reimbursement, and can plan sponsors trace reported savings to net plan economics?

Abstract Medicare Part D payment traceability visual with layered data pathways and oversight grids.

Healthcare compliance

Medicare Part D Payment Data Gap: What HHS OIG Could Not Trace

HHS OIG found similar net drug costs for selected Medicare Part D drugs, but different payment paths and incomplete pharmacy-level DIR traceability.

Abstract PBM transparency visual showing fee disclosure pathways, governance traceability, and regulatory oversight signals.

Healthcare enforcement

PBM Transparency Moves From Reform Proposal to Pricing Design

Optum Rx’s fee-based PBM model adds market context to DOL’s proposed PBM fee-disclosure rule and the broader push for compensation transparency.

Abstract signal grid showing regulatory disclosure flows resolving into auditable pathways with oversight checkpoints and fiduciary traceability

Healthcare enforcement

DOL’s PBM Transparency Proposal Is Now Drawing a Scope Fight

DOL’s proposed PBM disclosure rule is still not final, but the comment period is closed and the real fight is now over scope, audit visibility, and how much compensation detail self-insured plan fiduciaries may ultimately receive.